Marc Goodman
Stock Analyst at Leerink Partners
(4.85)
# 369
Out of 4,630 analysts
843
Total ratings
56%
Success rate
19.1%
Average return
Main Sectors:
Stocks Rated by Marc Goodman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NGEN NervGen Pharma | Initiated Coverage: Buy | $10 | $1.70 | +488.24% | 1 | Jul 13, 2026 | |
| RAPP Rapport Therapeutics | Initiated Coverage: Buy | $52 | $46.98 | +10.69% | 1 | Jun 24, 2026 | |
| STOK Stoke Therapeutics | Maintained: Buy | n/a | $32.23 | - | 11 | Jun 2, 2026 | |
| SPTX Seaport Therapeutics | Initiated Coverage: Buy | $35 | $22.86 | +53.11% | 1 | May 27, 2026 | |
| ACIU AC Immune | Maintained: Buy | n/a | $2.28 | - | 38 | Apr 7, 2026 | |
| ALKS Alkermes | Maintained: Hold | n/a | $49.40 | - | 45 | Mar 31, 2026 | |
| SGP SpyGlass Pharma | Initiated Coverage: Buy | $42 | $25.16 | +66.93% | 1 | Mar 3, 2026 | |
| MANE Veradermics | Initiated Coverage: Buy | $75 | $110.75 | -32.28% | 1 | Mar 2, 2026 | |
| NMRA Neumora Therapeutics | Initiated Coverage: Buy | $8 | $1.62 | +393.83% | 1 | Jan 11, 2026 | |
| BHVN Biohaven | Maintained: Buy | $50 → $15 | $14.54 | +3.16% | 26 | Dec 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $12.18 | +146.31% | 1 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $2.62 | +90.84% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $167.28 | -49.19% | 13 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $12.76 | +291.85% | 13 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $30 | $29.39 | +2.08% | 46 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $207.13 | - | 58 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $215 | $256.52 | -16.19% | 54 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $64.23 | - | 31 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $220.89 | - | 52 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.57 | - | 42 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $20 | $22.67 | -11.78% | 34 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $45.79 | -25.74% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $164.92 | - | 48 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $3.94 | +407.61% | 4 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $25.00 | +60.00% | 16 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.51 | +562.25% | 40 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $45.15 | n/a | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $5.36 | n/a | 11 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.54 | n/a | 33 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1 | $0.022 | n/a | 9 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $261.81 | n/a | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $13.54 | n/a | 17 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $2.10 | n/a | 1 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $78.28 | n/a | 10 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $70 | $0.659 | n/a | 12 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.13 | n/a | 2 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $53.75 | n/a | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $148.72 | n/a | 1 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $41.02 | n/a | 1 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $277.00 | n/a | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $523.91 | n/a | 2 | Mar 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $473 | $808.05 | n/a | 1 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $72 → $57 | $64.84 | n/a | 17 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $54 | $16.28 | n/a | 8 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $27.05 | n/a | 15 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $34 → $20 | $36.14 | n/a | 26 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $130.92 | n/a | 16 | Oct 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $95 | $247.97 | n/a | 14 | Oct 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $98 | $12.64 | n/a | 8 | Oct 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $85 | $1,231.94 | n/a | 12 | Jul 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $28 → $12 | $17.88 | n/a | 8 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $118 | $133.06 | n/a | 3 | Nov 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 | $4.05 | n/a | 3 | Jun 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $8.83 | n/a | 24 | Mar 21, 2016 |
NervGen Pharma
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $1.70
Upside: +488.24%
Rapport Therapeutics
Jun 24, 2026
Initiated Coverage: Buy
Price Target: $52
Current: $46.98
Upside: +10.69%
Stoke Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $32.23
Upside: -
Seaport Therapeutics
May 27, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $22.86
Upside: +53.11%
AC Immune
Apr 7, 2026
Maintained: Buy
Price Target: n/a
Current: $2.28
Upside: -
Alkermes
Mar 31, 2026
Maintained: Hold
Price Target: n/a
Current: $49.40
Upside: -
SpyGlass Pharma
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $42
Current: $25.16
Upside: +66.93%
Veradermics
Mar 2, 2026
Initiated Coverage: Buy
Price Target: $75
Current: $110.75
Upside: -32.28%
Neumora Therapeutics
Jan 11, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $1.62
Upside: +393.83%
Biohaven
Dec 25, 2025
Maintained: Buy
Price Target: $50 → $15
Current: $14.54
Upside: +3.16%
Nov 21, 2025
Initiated Coverage: Buy
Price Target: $30
Current: $12.18
Upside: +146.31%
Nov 17, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $2.62
Upside: +90.84%
Oct 15, 2025
Reiterated: Buy
Price Target: $85
Current: $167.28
Upside: -49.19%
Oct 9, 2025
Reiterated: Buy
Price Target: $50
Current: $12.76
Upside: +291.85%
Oct 7, 2025
Maintained: Buy
Price Target: $32 → $30
Current: $29.39
Upside: +2.08%
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $207.13
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: $215
Current: $256.52
Upside: -16.19%
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $64.23
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $220.89
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $7.57
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: $10 → $20
Current: $22.67
Upside: -11.78%
Oct 6, 2025
Initiated Coverage: Buy
Price Target: $34
Current: $45.79
Upside: -25.74%
Sep 23, 2025
Maintained: Buy
Price Target: n/a
Current: $164.92
Upside: -
Sep 16, 2025
Reiterated: Buy
Price Target: $20
Current: $3.94
Upside: +407.61%
Aug 13, 2025
Maintained: Buy
Price Target: $40
Current: $25.00
Upside: +60.00%
Aug 12, 2025
Maintained: Buy
Price Target: $10
Current: $1.51
Upside: +562.25%
Aug 1, 2025
Reiterated: Buy
Price Target: $20
Current: $45.15
Upside: n/a
Aug 1, 2025
Maintained: Buy
Price Target: $36
Current: $5.36
Upside: n/a
May 13, 2025
Maintained: Hold
Price Target: n/a
Current: $4.54
Upside: n/a
Mar 26, 2025
Downgraded: Hold
Price Target: $1
Current: $0.022
Upside: n/a
Jan 13, 2025
Maintained: Buy
Price Target: n/a
Current: $261.81
Upside: n/a
May 12, 2023
Maintained: Buy
Price Target: $4
Current: $13.54
Upside: n/a
Jan 24, 2023
Initiated Coverage: Buy
Price Target: $24
Current: $2.10
Upside: n/a
Jul 11, 2022
Maintained: Hold
Price Target: $20
Current: $78.28
Upside: n/a
Jul 11, 2022
Maintained: Hold
Price Target: $70
Current: $0.659
Upside: n/a
Jun 27, 2022
Maintained: Hold
Price Target: n/a
Current: $6.13
Upside: n/a
May 3, 2022
Maintained: Buy
Price Target: n/a
Current: $53.75
Upside: n/a
May 13, 2021
Maintained: Buy
Price Target: $25
Current: $148.72
Upside: n/a
May 4, 2021
Reiterated: Buy
Price Target: n/a
Current: $41.02
Upside: n/a
Apr 5, 2021
Maintained: Buy
Price Target: $31
Current: $277.00
Upside: n/a
Mar 19, 2019
Downgraded: Hold
Price Target: n/a
Current: $523.91
Upside: n/a
Nov 12, 2018
Initiated Coverage: Buy
Price Target: $473
Current: $808.05
Upside: n/a
May 21, 2018
Downgraded: Hold
Price Target: $72 → $57
Current: $64.84
Upside: n/a
Mar 1, 2018
Reiterated: Buy
Price Target: $46 → $54
Current: $16.28
Upside: n/a
Jan 31, 2018
Maintained: Buy
Price Target: $42
Current: $27.05
Upside: n/a
Dec 18, 2017
Maintained: Hold
Price Target: $34 → $20
Current: $36.14
Upside: n/a
Oct 30, 2017
Maintained: Buy
Price Target: $67
Current: $130.92
Upside: n/a
Oct 13, 2017
Maintained: Hold
Price Target: $95
Current: $247.97
Upside: n/a
Oct 5, 2017
Reiterated: Buy
Price Target: $110 → $98
Current: $12.64
Upside: n/a
Jul 26, 2017
Maintained: Hold
Price Target: $85
Current: $1,231.94
Upside: n/a
Nov 10, 2016
Reiterated: Sell
Price Target: $28 → $12
Current: $17.88
Upside: n/a
Nov 2, 2016
Maintained: Buy
Price Target: $118
Current: $133.06
Upside: n/a
Jun 14, 2016
Maintained: Sell
Price Target: $8
Current: $4.05
Upside: n/a
Mar 21, 2016
Rated: Buy
Price Target: n/a
Current: $8.83
Upside: n/a